S. El-Kafrawy

Host cell entry receptors as pharmacological targets in respiratory viral infections: from biology to clinical translation

Host receptor targeting is a mechanistically rational but still clinically unproven component of the respiratory antiviral landscape; its value is most plausibly realised in defined niches—prophylaxis, early outpatient treatment, and combination with direct-acting antivirals—and within pandemic preparedness frameworks,...